Debtor distribution data (CK92) - Nykredit Realkredit A/S
To the Nasdaq Copenhagen
Debtor distribution data (CK92)
Pursuant to s 24 Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes debtor distribution data for callable mortgage bond series as at 20 January 2023 in the attached file.
Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/filarkiv/.
For further information about data format and contents, please refer to the Nasdaq website.
Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21.
Yours sincerely
Nykredit Realkredit A/S
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Heineken Holding N.V. reports on 2024 first-quarter trading24.4.2024 08:01:00 CEST | Press release
Amsterdam, 24 April 2024 – Heineken Holding N.V. (EURONEXT: HEIO; OTCQX: HKHHY) publishes its trading update for the first quarter of 2024. Key Highlights Revenue €8,184 million, up 7.2%Net revenue (beia) organic growth 9.4%; per hectolitre 4.9%Beer volume organic growth 4.7%Premium beer volume organic growth 7.3%Heineken® volume growth 12.9%Gross merchandise value captured via eB2B platforms +17%Outlook for the full year unchanged; operating profit (beia) expected to grow organically low- to high-single-digit. Heineken Holding N.V. engages in no activities other than its participating interest in Heineken N.V. and the management or supervision of and provision of services to that company. Financial Summary Throughout this report figures refer to quarterly performance unless otherwise indicated. Revenue in the first quarter was €8.2 billion, up 7.2%. Net revenue (beia) was €6.8 billion, up 9.4% organically. Total consolidated volume increased 4.3% and net revenue (beia) per hectolitre
Heineken N.V. reports on 2024 first-quarter trading24.4.2024 08:00:00 CEST | Press release
Amsterdam, 24 April 2024 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) publishes its trading update for the first quarter of 2024. Key Highlights Revenue €8,184 million, up 7.2%Net revenue (beia) organic growth 9.4%; per hectolitre 4.9%Beer volume organic growth 4.7%Premium beer volume organic growth 7.3%Heineken® volume growth 12.9%Gross merchandise value captured via eB2B platforms +17%Outlook for the full year unchanged; operating profit (beia) expected to grow organically low- to high-single-digit. CEO Statement Dolf van den Brink, Chairman of the Executive Board / CEO, commented: "As we maintained focus on our EverGreen priorities, we had an encouraging start to 2024. All regions grew volume and net revenue, and we continued to see a sequential improvement in the performance of the business, growing in line or ahead of the category in the majority of our markets. This quarter was boosted by an earlier Easter and cycling negative one-off effects from last year. Top-line delivery w
Pharming Group to report first quarter 2024 financial results on May 824.4.2024 08:00:00 CEST | Press release
Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) first quarter 2024 financial results, for the period ended March 31, on Wednesday, May 8, 2024. Pharming will host a presentation for analysts and investors at 13:30 CEST/07:30 am EDT on May 8, 2024. To participate in the conference call, please register in advance using the link below. Once registered, dial-in information and a unique PIN will be provided, allowing access to the call. Conference call registration: Please note, the Company will only take questions from dial-in attendees. https://register.vevent.com/register/BI6f55067b569a46d7a67be9f94edefc95 To watch the live webcast, please register in advance using the link below. Webcast registration: https://edge.media-server.com/mmc/p/ov2ruv3b About Pharming Group N.V. Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company
EXEL Industries : Second quarter 2023–2024 sales: up 1.8%24.4.2024 07:55:00 CEST | Press release
Second quarter 2023-2024 sales: down 1.8% Varying sales performance across activities Q2 sales (January 2024–March 2024) 2022-20232023-2024Change (reported)Change (LFL*) Reported Reported €m % €m % AGRICULTURAL SPRAYING 147.7157.4 +9.7 +6.5% +12.0 +8.1% SUGAR BEET HARVESTERS 34.317.1 -17.2 -50.1% -17.1 -49.9% LEISURE 48.447.4 -1.0 -2.0% -4.4 -9.0% INDUSTRY 67.670.7 +3.1 +4.7% +3.3 +4.9%EXEL Industries Group297.9292.6 -5.3 -1.8% -6.2 -2.1% 6-month sales (October 2023–March 2024) 2022-20232023-2024Change (reported)Change (LFL*) Reported Reported €m % €m % AGRICULTURAL SPRAYING 236.8248.3 +11.6 +4.9% +17.0 +7.2% SUGAR BEET HARVESTERS 53.844.2 -9.6 -17.8% -8.5 -15.9% LEISURE 62.158.5 -3.6 -5.9% -8.8 -14.1% INDUSTRY 130.4141.7 +11.3 +8.7% +14.4 +11.0%EXEL Industries Group483.1492.7 +9.7 +2.0% +14.1 +2.9% * Like-for-like (LFL) = at constant consolidation scope and foreign exchange rates Second quarter 2023-2024 sales The EXEL Industries Group posted revenue of €292.6 million for the second q
Vistin Pharma ASA: First quarter 2024 financial results24.4.2024 07:44:00 CEST | Press release
Oslo, Norway, 24th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2024. Revenue in the first quarter ended at MNOK 104 compared to MNOK 101 in Q1 2023. Sales volume in the quarter was up by 11% compared to Q1 2023. First quarter EBITDA ended at MNOK 20 compared to MNOK 14 in Q1 2023, representing a 45% increase. EBITDA positively affected by increased sales volume and product mix, partly offset by a one-time inventory adjustment of MNOK 7. The net profit ended at MNOK 7.7 for the first quarter of 2024. Net profit negatively affected with approx. MNOK 3 in the quarter by fair value of future FX cash flow hedging contracts (unrealized gain - no cash effect in quarter). Unplanned “wear and tear” maintenance/repair on Line 2 resulted in lower than planned production and sales volume in the first quarter. After the repair, line 2 has been producing according to plan from fiscal week 14. The first quarter conference call, which will be